Offer - Urjas Oil for just ₹ 1
Olmecip is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of High BP. The alternative uses of Olmecip have also been explained below.
The right dosage of Olmecip depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Common side effects of Olmecip include Upper respiratory tract infection. Besides the aforementioned side effects, there are other adverse effects of Olmecip as well, which are listed below. Such side effects of Olmecip normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Olmecip is Severe for pregnant women and Mild for women who are breastfeeding. Warnings related to Olmecip's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension) must refrain from the use of Olmecip since this can cause severe adverse effects. Some other conditions that can be affected by Olmecip are listed in the contraindications section below.
Additionally, Olmecip may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Olmecip is not safe while driving, and is is not addictive in nature.
Olmecip is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Olmecip safe for pregnant women?
Pregnant women may get severe side effects after taking Olmecip. If you are pregnant, do not take Olmecip without a doctor's advice.
Is the use of Olmecip safe during breastfeeding?
Olmecip has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olmecip on the Kidneys?
Very few cases of side effects of Olmecip on kidney have been reported.
What is the effect of Olmecip on the Liver?
Very few cases of side effects of Olmecip on the liver have been reported.
What is the effect of Olmecip on the Heart?
Olmecip may have mild side effects on the heart. Most people will never see any effect on the heart.
Olmecip should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmecip unless your doctor advises you to do so -
Is this Olmecip habit forming or addictive?
No, you will not get addicted to Olmecip.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Olmecip. So it is best to avoid driving.
Is it safe?
Yes, but take Olmecip only as per medical advice.
Is it able to treat mental disorders?
No, Olmecip is not used to treat mental disorders.
Interaction between Food and Olmecip
When consumed with certain foods, Olmecip may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Olmecip
Consumption of alcohol and Olmecip together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
